D
Mirum Pharmaceuticals, Inc. MIRM
$68.38 -$1.71-2.44% NASDAQ
Recommendation
Prev Close
$72.65
Volume
203,319
Avg Vol (90D)
646,413
Market Cap
$3.65B
Dividend & Yield
--
52-Week Range
$36.88 - $78.54
P/E (TTM)
--
EPS (TTM)
-$1.22
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Citizens Jmp Forecasts Strong Price Appreciation for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock
11/6/2025 - MarketBeat
How Mirum's Profit Turnaround and Raised Guidance Will Impact Mirum Pharmaceuticals (MIRM) Investors
11/5/2025 - Simply Wall St
Mirum Pharmaceuticals (MIRM): Cantor Fitzgerald Raises Price Target to $95 MIRM Stock News
11/5/2025 - GuruFocus
MIRM's Q3 Earnings & Revenues Beat Estimates, 2025 View Tightened
11/5/2025 - Zacks Investment Research
Stifel Nicolaus Sticks to Its Buy Rating for Mirum Pharmaceuticals (MIRM)
11/5/2025 - TipRanks Financial Blog
Mirum Pharmaceuticals (MIRM) Projected to Post Earnings on Tuesday
11/5/2025 - MarketBeat
Mirum Pharmaceuticals price target raised by $10 at Cantor Fitzgerald, here's why
11/5/2025 - The Fly
Mirum Pharmaceuticals (MIRM): Analyst Rating Update Raises Price Target MIRM Stock News
11/5/2025 - GuruFocus
Citizens Jmp Forecasts Strong Price Appreciation for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock
11/5/2025 - Ticker Report
Mirum Pharmaceuticals (MIRM) Target Price Raised by HC Wainwright & Co. MIRM Stock News
11/5/2025 - GuruFocus
What Analysts Are Saying About Mirum Pharmaceuticals Stock
11/5/2025 - Benzinga
Mirum Pharmaceuticals price target raised to $81 from $80 at H.C. Wainwright
11/5/2025 - TipRanks Financial Blog
Mirum Pharmaceuticals price target raised by $1 at H.C. Wainwright, here's why
11/5/2025 - The Fly
Mirum Pharmaceuticals price target raised by $14 at Citizens JMP, here's why
11/5/2025 - The Fly
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Consensus Recommendation of "Buy" by Brokerages
11/5/2025 - MarketBeat
Decoding Mirum Pharmaceuticals Inc (MIRM): A Strategic SWOT Insight
11/5/2025 - GuruFocus
Mirum Pharmaceuticals Reports Strong Q3 2025 Growth
11/5/2025 - TipRanks Financial Blog
Mirum Pharmaceuticals Inc (MIRM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...
11/5/2025 - GuruFocus
Q3 2025 Mirum Pharmaceuticals Inc Earnings Call Transcript
11/5/2025 - GuruFocus
Mirum Pharmaceuticals, Inc. (MIRM) Q3 2025 Earnings Call Transcript
11/4/2025 - SeekingAlpha
Mirum Pharmaceuticals, Inc. (MIRM) Q3 2025 Earnings Call Transcript
11/4/2025 - Seeking Alpha: Transcripts
Mirum Pharmaceuticals (MIRM) Projects 2025 Sales Between $500M and $510M
11/4/2025 - GuruFocus
Mirum Pharmaceuticals, Inc. (MIRM) Surpasses Q3 Earnings and Revenue Estimates
11/4/2025 - Zacks Investment Research
Mirum Pharmaceuticals sees FY25 product sales of $500M-$510M, consensus $506.3M
11/4/2025 - The Fly
Mirum Pharmaceuticals reports Q3 EPS 5c, consensus (16c)
11/4/2025 - The Fly
Income Statement
Total Revenue (TTM)
$429.16M
EBITDA (TTM)
-$32.86M
EBIT (TTM)
-$57.08M
Net Income (TTM)
-$58.56M
Balance Sheet
Total Assets (Q)
$725.83M
Total Debt (Q)
$318.90M
Total Liabilities (Q)
$470.67M
Book Value Per Share (Q)
$5.10
Cash Flow
Cash from Operations (TTM)
$9.00M
Cash from Investing (TTM)
-$40.13M
Cash from Financing (TTM)
$24.25M
Net Change in Cash (TTM)
-$4.89M
Filings
Filing Date
Wednesday, August 6, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
0.76
7-Day Total Return
-1.48%
30-Day Total Return
-7.51%
60-Day Total Return
14.02%
90-Day Total Return
35.25%
Year to Date Total Return
62.65%
1-Year Total Return
69.26%
2-Year Total Return
140.61%
3-Year Total Return
196.15%
5-Year Total Return
315.18%
52-week Low
Apr 09, 2025 - $36.88
52-week High
Oct 09, 2025 - $78.54
Valuation
Market Cap
$3.65B - Mid Cap
Enterprise Value
$3.66B
Price/Sales (TTM)
8.42
Price/Book (Q)
14.25
Dividends and Shares
Shares Outstanding
49.73
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.mirumpharma.com
Phone Number
650 667 4085
Address
950 Tower Lane
Foster City, CA 94404
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate... more
NASDAQ 11/06/2025 12:58PM Eastern Quotes delayed